News

Deal Announcements

Altea Therapeutics Secures More Venture Capital Debt

Tuesday, October 26, 2010 5:32:00 AM PDT | VentureDeal Staff
Atlanta, Georgia  --  Pharmaceutical company Altea Therapeutics has secured $685,000 in venture capital debt financing, according to an SEC regulatory filing.

Altea is developing pharmaceutical products based on a new class of advanced transdermal patches.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1